Our new biomarker booklet is out!

Mon Mar 02 2020

Our new booklet “Inflammatory Biomarkers For Clinical Use” is ready for you to read now!

The use of biomarkers in clinical research and clinical practice has become a big part of patient risk assessment. In this booklet we address six biomarkers in more detail: suPAR, CRP, PCT, Pro-ADM, ESR, and IL-6, which are used as routine biomarkers for immune and inflammation status in acute medical patients.

Please find the booklet here.

+800

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 3 products:

Photo of The suPARnostic® Quick Triage kit

Quick Triage

A Point of Care Solution

Photo of suPARnostic® TurbiLatex

TurbiLatex

For Automated Systems

Photo of suPARnostic® ELISA

ELISA Assay

Clinical and Research

suPAR is used in clinical routine in 38 hospitals

38 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling. This period covers October 1, 2021, until September 30, 2022.
Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates